Conditions: Chronic Kidney Disease Hyperparathyroidism, Secondary Secondary Hyperparathyroidism
Keywords: pediatric CKD dialysis paediatric
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 14
Healthy volunteers: no

Brief summary:
The primary objective of the study was to evaluate the safety and tolerability of cinacalcet after a single oral dose in children aged 28 days to less than 6 years with chronic kidney disease receiving dialysis.

Detailed description:

Arms:
arm 1: Participants received a single, oral dose of 0.25 mg/kg cinacalcet.

Interventions: intervention 1: Cinacalcet
Intervention descriptions: intervention 1: Single, oral dose of 0.25 mg/kg cinacalcet

Protocol document: